CSIMarket Company Name, Ticker, Suppliers, else..
 

Sorrento Therapeutics Inc   (SRNEQ)

Sorrento Therapeutics Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

SRNEQ Sales vs. its Competitors Q2 2023


Comparing the current results to its competitors, Sorrento Therapeutics Inc reported Revenue increase in the 2 quarter 2023 by 31.1 % year on year, while most of its competitors have experienced contraction in revenues by -13.93 %, achieved in the same quarter.

• List of SRNEQ Competitors





Revenue Growth Comparisons




Net Income Comparison

Sorrento Therapeutics Inc , slower than the average decrease reported by the company's competitors of -78.47 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -78.47 %

<<  SRNEQ Stock Performance Comparisons





  

Overall company Market Share Q2 2023
Due to strong revenue growth of 31.1 % in Overall company Sorrento Therapeutics Inc improved its market share, to approximately 0.08 %.


<<  More on SRNEQ Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Sorrento Therapeutics Inc




Vaxart Inc
Share Performance



-1.30%
Over The Past 5 Days
Vaxart Inc
Profile

Vaxart Inc's business model involves the development of oral vaccines through their proprietary tablet vaccine delivery platform.

More about Vaxart Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 119.509 mill. $ 243.064 mill. $ 38.589 mill.


Novavax inc
Share Performance



+10.37%
Over The Past 5 Days
Novavax inc
Profile

Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market.

More about Novavax inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,668.681 mill. $ 596.338 mill. $ -87.835 mill.


Moderna Inc
Share Performance



+371.65%
This Year
Moderna Inc
Profile

Moderna Inc's business model revolves around the development and commercialization of mRNA-based therapeutics and vaccines. They focus on using messenger RNA (mRNA) technology to create drugs that can help prevent and treat various diseases.

More about Moderna Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 57,928.900 mill. $ 2,228.000 mill. $ -3,151.000 mill.


Molecular Partners Ag
Share Performance



+7.94%
This Quarter
Molecular Partners Ag
Profile

Molecular Partners Ag is a biotechnology company that operates on an innovative business model focused on the development of therapeutic drugs. The company utilizes its proprietary DARPin technology platform to create a pipeline of potential treatments for various diseases. Molecular Partners Ag primarily collaborates with strategic partners, including pharmaceutical companies, to advance its drug candidates through preclinical and clinical development stages.

More about Molecular Partners Ag's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 162.130 mill. $ - mill. $ -61.651 mill.


Invivyd Inc
Share Performance



-27.54%
One Year
Invivyd Inc
Profile

Invivyd Inc is a company that operates on a particular business model to deliver its products or services, but without providing any further details.

More about Invivyd Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 264.679 mill. $ 58.365 mill. $ -107.333 mill.

34 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Sorrento Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sorrento Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.